Variant report
Variant | nsv460799 |
---|---|
Chromosome Location | chr3:103122585-103212708 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZPLD1-8 | chr3:103198015-103199460 | l_2420_NR_026934 |
2 | lnc-ZPLD1-8 | chr3:103161896-103161996 | l_2420_NR_026934 |
3 | lnc-ZPLD1-8 | chr3:103142393-103142559 | l_2420_NR_026934 |
4 | lnc-ZPLD1-8 | chr3:103196095-103196431 | l_2420_NR_026934 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11921425 | chr3:103122585-103122586 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs530501412 | chr3:103122594-103122595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528726277 | chr3:103128813-103128814 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377116457 | chr3:103128817-103128818 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375046739 | chr3:103128867-103128868 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548372872 | chr3:103128886-103128887 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146278748 | chr3:103128925-103128926 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187324745 | chr3:103128930-103128931 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529804004 | chr3:103128981-103128982 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192817318 | chr3:103129005-103129006 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569639859 | chr3:103129052-103129053 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536939519 | chr3:103129071-103129072 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550160652 | chr3:103129094-103129095 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184508320 | chr3:103142394-103142395 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs11715084 | chr3:103142395-103142396 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs148256020 | chr3:103142407-103142408 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs531132109 | chr3:103142423-103142424 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs556292562 | chr3:103142424-103142425 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs140708116 | chr3:103142477-103142478 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs552418918 | chr3:103142486-103142487 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs368539719 | chr3:103142547-103142548 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs577691351 | chr3:103142558-103142559 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs145589490 | chr3:103161918-103161919 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs148452633 | chr3:103161929-103161930 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs75192144 | chr3:103165020-103165021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9874536 | chr3:103165026-103165027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537584226 | chr3:103165041-103165042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561517657 | chr3:103165050-103165051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555819527 | chr3:103165061-103165062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143424212 | chr3:103165117-103165118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34315822 | chr3:103165166-103165167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79158311 | chr3:103165174-103165175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554045699 | chr3:103165179-103165180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs114190300 | chr3:103165187-103165188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75187352 | chr3:103165189-103165190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114954410 | chr3:103165190-103165191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138654842 | chr3:103165232-103165233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544762371 | chr3:103165255-103165256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185131294 | chr3:103165313-103165314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191080479 | chr3:103165315-103165316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181823807 | chr3:103165341-103165342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560863296 | chr3:103165342-103165343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527945751 | chr3:103165344-103165345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142772751 | chr3:103165345-103165346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73150912 | chr3:103165362-103165363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs59375912 | chr3:103165417-103165418 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs530580995 | chr3:103165497-103165498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368248201 | chr3:103165503-103165504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs57084212 | chr3:103165518-103165519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6793955 | chr3:103165552-103165553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:103121800-103122600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr3:103128800-103129200 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
3 | chr3:103165000-103165800 | Enhancers | Stomach Mucosa | stomach |
4 | chr3:103165600-103166000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr3:103166400-103166600 | Enhancers | Fetal Kidney | kidney |
6 | chr3:103166800-103167000 | ZNF genes & repeats | Fetal Kidney | kidney |
7 | chr3:103168800-103169200 | Active TSS | Psoas Muscle | Psoas |
8 | chr3:103181200-103181600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr3:103189400-103189600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr3:103202800-103203200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |